Skip to main content

Find Clinical Trials

Home
Conditions
Cholangiocarcinoma

Clinical trial condition

Cholangiocarcinoma

Explore clinical trials studying Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.

269 public trials 77 recruiting studies

Refine in advanced search Browse all conditions

Cholangiocarcinoma trial results

Not Yet Recruiting

Precision Integrated Strategies and Efficacy Evaluation for Biliary Tract Cancers: An Umbrella Platform Study

NCT07729917

Conditions: Adenocarcinoma, Bile Duct Carcinoma, Bile Duct Diseases, +11 more
Locations: The First Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Not Yet Recruiting

Breath Research Narrow Validation for Gastrointestinal Cancer Detection

NCT07714538

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +35 more
Locations: Maidstone and Tunbridge Wells NHS Trust Maidstone, Kent, United Kingdom

Liverpool University Hospitals NHS Foundation Trust Liverpool, Merseyside, United Kingdom

NHS Greater Glasgow and Clyde Glasgow, United Kingdom

The Clatterbridge Cancer Centre NHS Foundation Trust Liverpool, United Kingdom

View Trial Details

Not Yet Recruiting

[18F]FTT Positron Emission Tomography/Computed Tomography to Predict Treatment Response in Patients Scheduled to Receive Gemcitabine, Cisplatin, and Durvalumab for Newly Diagnosed Cholangiocarcinoma

NCT07673341

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Not Yet Recruiting

Suprapapillary Metal Stent vs. Routine Transpapillary Drainage in Malignant Hilar Biliary Obstruction (SMART-B Trial)

NCT07558304

Conditions: Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +11 more
Locations: Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil

View Trial Details

Not Yet Recruiting

A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.

NCT07623642

Conditions: Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +55 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China

View Trial Details

Not Yet Recruiting

EYEMAX® Versus SPYGLASS™ DS for Biliary Stricture Diagnosis

NCT07620080

Conditions: Adenocarcinoma, Biliary Stricture, Carcinoma, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Study of Becotatug Vedotin Added to Standard Treatment for Advanced Bile Duct Cancer With EGFR Mutations

NCT07598318

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Adebrelimab Plus S-1 for Resected Cholangiocarcinoma

NCT07561775

Conditions: Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Outcomes After Liver and Biliary Resection at a High-Volume Center

NCT07556835

Conditions: Adenocarcinoma, Benign Liver Disease, Biliary Tract Diseases, +22 more
Locations: San Jacopo Hospital Pistoia, Tuscany, Italy

View Trial Details

Not Yet Recruiting

The Efficacy and Safety of Pucotenlimab (PD-1) Combined With Becotatugvedotin (EGFR-ADC) in Advanced Cholangiocarcinoma

NCT07514533

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
Locations: Not specified

View Trial Details